title: [Management of testicular teratoma: update by the Oncology Committee of the French Urology Association, section of External Genital Organs (CCAFU-OGE)].
abstract: BACKGROUND
  The objective of this article was to focus on the pathological, clinical and therapeutic aspects of the different forms of testicular teratoma in adults.
  
  
  METHODS
  The multidisciplinary working group has conducted a literature search on Pubmed with keywords: adult teratoma; malignant transformation; growing teratoma; chemotherapy; surgery with focus on the different forms of adult testicular teratoma.
  
  
  RESULTS
  Teratomas of the adults are malignant and subdivided into localized and metastatic forms that may be distinguished under exclusive teratoma form, growing teratoma or teratoma with malignant transformation. The management is based on an enlarged surgical excision (testis and metastasis) with, in metastatic forms, a chemotherapy adjusted with histology. Extended follow-up beyond 10 years is necessary because of the risk of late relapse.
  
  
  CONCLUSIONS
  Testicular teratoma is a rare tumor, which is considered malignant with a potential of metastasis. The treatment is based mainly on surgical management.
authors.affiliation: Service d'urologie, clinique Kennedy, 30000 Nîmes, France.
authors.forename: C
authors.initials: C
authors.lastname: Avances
authors.affiliation: Centre de pathologie, 80000 Amiens, France.
authors.forename: P
authors.initials: P
authors.lastname: Camparo
authors.affiliation: Service d'urologie, hôpital Val-de-Grâce, 75014 Paris, France.
authors.forename: X
authors.initials: X
authors.lastname: Durand
authors.affiliation: Service d'oncologie médicale, centre Léon-Bérard, 69008 Lyon, France.
authors.forename: A
authors.initials: A
authors.lastname: Flechon
authors.affiliation: Service d'urologie, hôpital Lapeyronie, 34295 Montpellier, France.
authors.forename: T
authors.initials: T
authors.lastname: Murez
authors.affiliation: Service d'urologie, groupe hospitalier Diaconnesses Croix Saint-Simon, 75012 Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Sebe
authors.affiliation: Service d'urologie, hôpital de Rangueil, 31059 Toulouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Soulie
authors.affiliation: Service d'urologie, hôpital hôtel-Dieu, 1, place Alexis-Ricordeau, 44000 Nantes, France. Electronic address: jrigaud@chu-nantes.fr.
authors.forename: J
authors.initials: J
authors.lastname: Rigaud
mesh_terms: D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D017024:Chemotherapy, Adjuvant; D003663:Decision Trees; D005602:France; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009919:Orchiectomy; D012307:Risk Factors; D013724:Teratoma / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D013736:Testicular Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome
keywords: Adult; Adulte; Cell transformation neoplastic; Chimiothérapie; Chirurgie; Drug therapy; Surgery; Teratoma; Testicule; Testis; Transformation maligne; Tératome